|Articles|March 1, 2002

Allovectin-7 immunotherapy induces responses

Systemic answers offer needed care alternative in treatment of refractorymetastatic melanoma patients

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME